Organicell Regenerative Medicine, Inc.
Organicell Regenerative Medicine, Inc. (OCEL) Insider Trading
Form 4 buy vs sell counts, ratio, and sentiment — switch this quarter or last 12 months; chart and transactions below.
SEC EDGAR · FMP · OCEL · as of Jun 8, 2026
Activity summary
Buy transactions
8
P-Purchase only
Sell transactions
2
12 Months
Buy/Sell ratio
4.00
Buy/Sell (by trades)
Overall sentiment
Organicell Regenerative Medicine, Inc. insiders have been net buyers of shares over the past 12 Months, which may signal confidence in the company's outlook.
▸ Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · Buy = P-Purchase only · Sell = S-Sale only
As of Jun 8, 2026
OCEL insider buying and selling by quarter
OCEL insider selling · OCEL insider buying stocks · quarterly insider activity
Mobile shows last 4Q · Desktop shows full 8Q
▸ Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · last 8 quarters
As of Jun 8, 2026
Recent insider transactions
OCEL executive sell shares · OCEL board member insider trading · OCEL insider trading SEC filing
Scroll horizontally to see all columns
| Date | Insider | Type | Shares | Value | Filing |
|---|---|---|---|---|---|
| Dec 19, 2023 | Leider Harry L. CEO · Director | Sale | 5,248 | $7K | Form 4 |
| Jul 7, 2023 | Skycrest Holdings, LLC 10 percent owner | Purchase | 320,710 | $3K | Form 4 |
| Jun 29, 2023 | Skycrest Holdings, LLC 10 percent owner | Purchase | 200,000 | $2K | Form 4 |
| Jun 28, 2023 | Skycrest Holdings, LLC 10 percent owner | Purchase | 400,000 | $4K | Form 4 |
| Jun 28, 2023 | Leider Harry L. CEO · Director | Purchase | 549,450 | $54K | Form 4 |
| Jun 26, 2023 | Skycrest Holdings, LLC 10 percent owner | Purchase | 800,000 | $7K | Form 4 |
| Oct 29, 2021 | Mitrani Albert CEO · Director | Other | 15,000,000 | — | Form 4 |
| Oct 29, 2021 | Mitrani Albert CEO · Director | Other | 15,000,000 | — | Form 4 |
| Oct 29, 2021 | MITRANI MARIA INES Chief Science Officer | Other | 15,000,000 | — | Form 4 |
| Oct 29, 2021 | MITRANI MARIA INES Chief Science Officer | Other | 15,000,000 | — | Form 4 |
| Oct 29, 2021 | Shapiro George Craig Chief Medical Officer · Director | Other | 5,000,000 | — | Form 4 |
| Oct 29, 2021 | Shapiro George Craig Chief Medical Officer · Director | Other | 5,000,000 | — | Form 4 |
| Oct 29, 2021 | BOTHWELL IAN T CFO · Director | Other | 15,000,000 | — | Form 4 |
| Oct 29, 2021 | BOTHWELL IAN T CFO · Director | Other | 15,000,000 | — | Form 4 |
| Jun 17, 2021 | Shapiro George Craig Chief Medical Officer · Director | Sale | 9,955 | $1K | Form 4 |
| Jun 17, 2021 | MITRANI MARIA INES Chief Science Officer | Sale | 5,228 | $732 | Form 4 |
| Jun 17, 2021 | MITRANI MARIA INES Chief Science Officer | Sale | 44,772 | $6K | Form 4 |
| Jun 17, 2021 | BOTHWELL IAN T CFO · Director | Sale | 50,000 | $7K | Form 4 |
| Jun 17, 2021 | Mitrani Albert President · Director | Sale | 50,000 | $7K | Form 4 |
| Jun 14, 2021 | Shapiro George Craig Chief Medical Officer · Director | Sale | 32,000 | $4K | Form 4 |
| Jun 15, 2021 | Shapiro George Craig Chief Medical Officer · Director | Sale | 50,000 | $8K | Form 4 |
| Jun 16, 2021 | Shapiro George Craig Chief Medical Officer · Director | Sale | 40,375 | $6K | Form 4 |
| Jun 16, 2021 | Shapiro George Craig Chief Medical Officer · Director | Sale | 21,079 | $3K | Form 4 |
| Jun 14, 2021 | MITRANI MARIA INES Chief Science Officer | Sale | 50,000 | $7K | Form 4 |
| Jun 15, 2021 | MITRANI MARIA INES Chief Science Officer | Sale | 50,000 | $8K | Form 4 |
Skycrest Holdings, LLC
10 percent owner
Date
Jul 7
Shares
320,710
Price
$0.01
Value
$3K
Skycrest Holdings, LLC
10 percent owner
Date
Jun 29
Shares
200,000
Price
$0.01
Value
$2K
Skycrest Holdings, LLC
10 percent owner
Date
Jun 28
Shares
400,000
Price
$0.01
Value
$4K
Leider Harry L.
CEO · Director
Date
Jun 28
Shares
549,450
Price
$0.10
Value
$54K
Skycrest Holdings, LLC
10 percent owner
Date
Jun 26
Shares
800,000
Price
$0.01
Value
$7K
MITRANI MARIA INES
Chief Science Officer
Date
Oct 29
Shares
15,000,000
Price
—
Value
—
MITRANI MARIA INES
Chief Science Officer
Date
Oct 29
Shares
15,000,000
Price
—
Value
—
Shapiro George Craig
Chief Medical Officer · Director
Date
Oct 29
Shares
5,000,000
Price
—
Value
—
Shapiro George Craig
Chief Medical Officer · Director
Date
Oct 29
Shares
5,000,000
Price
—
Value
—
Shapiro George Craig
Chief Medical Officer · Director
Date
Jun 17
Shares
9,955
Price
$0.14
Value
$1K
MITRANI MARIA INES
Chief Science Officer
Date
Jun 17
Shares
5,228
Price
$0.14
Value
$732
MITRANI MARIA INES
Chief Science Officer
Date
Jun 17
Shares
44,772
Price
$0.14
Value
$6K
Mitrani Albert
President · Director
Date
Jun 17
Shares
50,000
Price
$0.14
Value
$7K
Shapiro George Craig
Chief Medical Officer · Director
Date
Jun 14
Shares
32,000
Price
$0.14
Value
$4K
Shapiro George Craig
Chief Medical Officer · Director
Date
Jun 15
Shares
50,000
Price
$0.16
Value
$8K
Shapiro George Craig
Chief Medical Officer · Director
Date
Jun 16
Shares
40,375
Price
$0.15
Value
$6K
Shapiro George Craig
Chief Medical Officer · Director
Date
Jun 16
Shares
21,079
Price
$0.15
Value
$3K
MITRANI MARIA INES
Chief Science Officer
Date
Jun 14
Shares
50,000
Price
$0.14
Value
$7K
MITRANI MARIA INES
Chief Science Officer
Date
Jun 15
Shares
50,000
Price
$0.16
Value
$8K
⚡ = value ≥ $1M · Award/Option price shows — · formType=4 · securityName=Common Stock · url → sec.gov/Archives/edgar
▸ Source: SEC EDGAR · Form 4 filings · ⚡ = value ≥ $1M · Award/Option price shows —
About OCEL insider trading
OCEL insider trades
Organicell Regenerative Medicine, Inc. (OCEL) insider trading data is sourced from SEC Form 4 filings submitted by corporate insiders, including OCEL. Over the past 12 months, 0 insiders have filed transactions with the SEC. OCEL insiders have been primarily buying, which may reflect pre-scheduled Rule 10b5-1 plan executions.
For Organicell Regenerative Medicine, Inc.'s institutional ownership breakdown and insider ownership percentage, see the Ownership tab → Ownership tab →
Frequently asked questions
OCEL insider trading · 5 questionsThe insiders of Organicell Regenerative Medicine, Inc. (OCEL) include executives and directors such as OCEL, among others. Over the past 12 months, 0 insiders have filed Form 4 transactions with the SEC. Insider transactions are required to be reported within 2 business days of the trade date.
▸ Source: FMP /stable/insider-trading/search · SEC EDGAR Form 3 & 4 · acquisitionOrDisposition A=Buy, D=Sell · RSU vesting (M-Exempt) excluded from sentiment bar · As of Jun 8, 2026